Back

Neurohormonal blockade in transthyretin amyloidosis: perhaps one size does not fit all?

European Heart Journal

24 May 2023
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HEART FAILURE Chronic Heart Failure

Contributors

Richard K Cheng
Richard K Cheng

Author

Sarah A M Cuddy
Sarah A M Cuddy

Author

Brigham and Women's Hospital Boston , United States of America

You may be interested in
thumbnail
Congress Presentation
Cardiac transthyretin wild-type amyloidosis (ATTRwt): a prospective study of 400 patients followed at the Italian referral center.
28 August 2020
thumbnail
Congress Presentation
Association of beta blocker therapy and functional parameters in patients with transthyretin amyloid cardiomyopathy
28 August 2026
thumbnail
Congress Session
Amyloidosis – what to look for?
17 May 2025
thumbnail
Congress Presentation
Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources